Highlights
-
Today’s Research Article: PRP beats steroids & PT in SAIS: more pain relief, better function, better QoL at 8 weeks.
-
Questions from the Field: Short-axis halo first, then long-axis—radial or ulnar entry both safe in the median-ulnar “safe zone.”
-
Let’s Get Down to Business: Pick one vivid patient avatar to attract the right clients—and stop saying yes to the wrong ones.
-
Come Join Us: October lineup: TrueMD Live (11–12), ICRS (13), Apex Lab (19), AOAO (23)—save your seat.
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Join Us at TrueMD Live — October 11–12 in Hollywood, Florida!
Don’t miss this unique opportunity to connect, learn, and grow with TrueMD. This year’s event will bring together leading voices in orthobiologics, innovation, and practice-building — and we want YOU to be part of it.
Reserve your spot today and take the next step toward transforming your practice.
Learn More and Register for TrueMD Live
Today’s Research Article
Comparison of the Effectiveness of Platelet-Rich Plasma, Corticosteroid, and Physical Therapy in Subacromial Impingement Syndrome
Tuğçe PASİN, Safinaz ATAOĞLU, Özge PASİN, Handan ANKARALI
Summary:
This study compared platelet-rich plasma (PRP) injections, corticosteroid injections, and physical therapy with exercise in 90 patients diagnosed with Stage 2 subacromial impingement syndrome (SAIS). All three treatments—when combined with exercise—significantly reduced pain, improved shoulder function, and enhanced quality of life after eight weeks. However, PRP produced greater improvements than the other treatments in pain during activity, shoulder function scores (UCLA SRS and QuickDASH), and the pain component of quality-of-life assessments.
Although PRP showed superior outcomes at eight weeks, the researchers emphasized that physical therapy and exercise remain the preferred first-line options due to being inexpensive, non-invasive, and free of adverse effects. Corticosteroid injections, while effective in the short term, are associated with risks such as tissue damage and often lead to recurrent symptoms. The authors concluded that PRP can provide added benefit in selected patients, particularly when conservative treatments alone are insufficient.
Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):
